BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6097354)

  • 1. Interactions between calcium antagonists, calcium fluxes and anthracycline transport.
    Kessel D; Wilberding C
    Cancer Lett; 1984 Nov; 25(1):97-101. PubMed ID: 6097354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D; Wilberding C
    Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D; Wilberding C
    Cancer Res; 1985 Apr; 45(4):1687-91. PubMed ID: 3919944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.
    Klohs WD; Steinkampf RW; Havlick MJ; Jackson RC
    Cancer Res; 1986 Sep; 46(9):4352-6. PubMed ID: 3460695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 6. Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
    Kessel D; Wilberding C
    Cancer Treat Rep; 1985 Jun; 69(6):673-6. PubMed ID: 4016770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance.
    Kessel D; Wilberding C; Karanes C; Ratanatharathorn V
    Cancer Lett; 1984 Oct; 24(3):305-9. PubMed ID: 6594191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
    Streeter DG; Johl JS; Gordon GR; Peters JH
    Cancer Chemother Pharmacol; 1986; 16(3):247-52. PubMed ID: 3457646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by non-antitumor anthracycline analogs.
    Inaba M; Nagashima K; Sakurai Y; Fukui M; Yanagi Y
    Gan; 1984 Dec; 75(12):1049-52. PubMed ID: 6597118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric monitoring of anthracycline transport in tumor cells.
    Krishan A
    Ann N Y Acad Sci; 1986; 468():80-4. PubMed ID: 3460483
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity to anthracyclines in P388/dx leukaemia cells.
    Bossa R; Dasdia T; Galatulas I; Zunino F
    Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 13. m-AMSA as a probe for transport phenomena associated with anthracycline resistance.
    Kessel D; Wheeler C
    Biochem Pharmacol; 1984 Apr; 33(7):991-3. PubMed ID: 6585205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
    Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH; Kessel D
    Biochem Pharmacol; 1981 Nov; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by perhexiline maleate.
    Ramu A; Fuks Z; Gatt S; Glaubiger D
    Cancer Res; 1984 Jan; 44(1):144-8. PubMed ID: 6690032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
    Krishan A; Sauerteig A; Gordon K; Swinkin C
    Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.